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Abstract Nanostructures are gaining interest in drug release
applications. Amphiphilic molecules can give, in water solu-
tion, a variety of nanostructures as well as thermodynamically
stable mesophases three-dimensional inverse cubic structures.
These mesophases are attractive candidates for biomedical
applications containing extensive water channel networks
and could act as very efficient delivery systems of drugs or
contrast agents. In order to discover, optimize, and develop
these systems, we have performed a deep physicochemical
characterization by dynamic light scattering and small-angle
neutron scattering of nanoparticles of monoolein (MO) and
Pluronic PF127, containing different amounts (1, 5, 10, and
20 %) of the synthetic amphiphilic gadolinium complex
(C18)2DTPA(Gd). Nanoparticle size is found in the 70–
400 nm range for all investigated systems; the morphology of
the aggregates is driven by the main constituents MO/PF127
and is a mixture of multilayer vesicles and bicontinuous ag-
gregates. Nanostructures are also able to encapsulate doxoru-
bicin (drug-loading content between 70 and 90 % for the
different systems) acting as a potential theranostic for simulta-
neous cancer therapy and MRI visualization.
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Introduction
Nanoscopic (10–500 nm) systems such as polymeric micelles,
dendrimers, liposomes, and inorganic nanoparticles that in-
corporate therapeutic agents, diagnostic probes, and mole-
cules for selective targeting are emerging as the next genera-
tion of multifunctional nanomedicines for improving the ther-
apeutic outcome of drug therapy [1]. The motivations for the
widespread of nanomedicine depend from the potential ad-
vantages of nanosystems with respect to conventional small
molecule-based therapy: high payload capacity, reduced tox-
icity to healthy tissue, and improved antitumor efficacy [2–4].
The term “theranostic” was recently coined to describe multi-
functional compounds able to combine diagnostic (PET and
SPECT in combination with CT and/or MRI) and therapeutic
modalities in one unified material, providing the chance to
develop individually designed therapies against various dis-
eases to accomplish personalized medicine [5]. Supramolec-
ular aggregates containing Gd(III) complexes have been re-
cently proposed as MRI contrast agents [6–9]. Liposomes,
obtained by self-assembling aggregation of lipophilic gado-
linium complexes or by their co-aggregation with surfactants,
and micelles, based on amphiphilic poly(gadolinium com-
plexes) polymers [10], display higher contrast efficacy with
respect to MRI contrast agent based on isolated gadolinium
complexes and peculiar pharmacokinetic properties. More-
over, gadolinium-based supramolecular aggregates could be
easily derivatized with bioactive targeting molecules, such as
peptides [8, 11–15] and antibodies [16–19]. These complex
structures have been recently proposed as target selectiveMRI
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contrast agents. Amphiphilic molecules could also aggregate
in water solution, giving a variety of higher order two (2D)- or
three-dimensional (3D) mesophases. Phases such as the 2D
inverse hexagonal or the 3D inverse cubic structures are
thermodynamically stable in water, and they can be dispersed
as stable submicron-sized particles [20]. The nanostructures
formed by dispersion of the bulk mesophases can offer sub-
stantial advantages with respect to traditional supramolecular
aggregates; in fact they present: (a) much higher payloads of
gadolinium ions compared to micellar and liposomal systems,
(b) an expected increased relaxivity rate (1/T1) due to the
slowing of the tumbling rate of the paramagnetic ions within
the dense and highly ordered packing in the two- and three-
dimensional networks of the hexagonal and cubic phases, and
(c) improved relaxivity values due to the presence of extensive
nanoscale water channels that offer a better environment for
diffusion and fast exchange between gadolinium-coordinated
water and bulk water. Contrast agents based on lanthanide
complexes in highly ordered two- or three-dimensional
mesophases have been initially proposed by Drummond
et al. [21–25]. Recently, we reported on the preparation,
structural characterization, and relaxometric behavior of new
gadolinium-based contrast agents obtained by co-aggregation
of an amphiphilic gadolinium complex, (C18)2DTPA(Gd),
with molar excesses of monoolein (MO) or diolein (DO)
(Fig. 1) [26]. The obtained nanostructures display high
relaxivity values and interesting relaxometric properties. We
used monoolein and diolein in the nanostructure preparation
for their known ability in giving highly ordered two- or three-
dimensional mesophases in aqueous solution; anyway, the
presence of the gadolinium-containing monomer seems to
produce a partial loss of the cubic symmetry.
These nanostructures are gaining interest also for their
potential application in controlled release and drug delivery.
The bicontinuous water and oil channels, in aggregates such
as cubosomes [27], allow for simultaneous incorporation of
hydrophilic and hydrophobic active principles. Moreover, the
pore structure provides a tortuous diffusion pathway for con-
trolled release [28]. Several formulations for oral, transdermal,
and systemic drug delivery have been recently proposed [29].
Here, we report a deep structural characterization by dynamic
light scattering (DLS) and small-angle neutron scattering
(SANS) of MO-based nanostructures doped with different
amounts (1, 5, 10, and 20 %) of the synthetic amphiphilic
gadolinium complex (C18)2DTPA(Gd) (Table 1). The goal of
these characterizations have two aims: determine the incidence
of other aggregates like vesicles have two aims could substituted
with are in these preparations and outline the best conditions for
the obtainment of well-defined and stable highly ordered three-
dimensional mesophases potentially acting as highly efficient
MRI contrast agents. Moreover, drug loading of the anticancer
doxorubicin (Dox) in monoolein-based nanostructures was also
investigated for potential theranostic applications.
Experimental
Materials
Monoolein (1-monooleoyl glycerol, MO) was purchased
by Sigma and had a purity of the acyl group (oleyl group)
>99 % and a purity of the ester (monoglyceride) >97 %.
A tri-block copolymer, containing ethylene oxide (EO)
and propylene oxide (PO) groups, with the trade name
Pluronic F127 (PF127) and an approximate formula of
EO98PO57EO98 (average molecular weight of 12,600 gmol
−1)
was obtained from BASF Svenska AB (Helsingborg,
Sweden). (C18H37)2NCO(CH2)2COLys(DTPA)CONH2,
[(C18)2DTPA], was synthesized by solid-phase methods and
purified by precipitation as previously described [30]. UV–vis
measurements were performed on a UV–vis Jasco V-5505
spectrophotometer (Easton, MD) equipped with a Jasco
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aFig. 1 Schematic representationof the commercially available
monoolein (a) and of
(C18H37)2NCO(CH2)2COLys(DTPA-
Gd)CONH2 [(C18)2DTPA(Gd)]
monomer (b)
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ETC-505 T Peltier temperature controller with a 1-cm quartz
cuvette (Hellma).
Synthesis of nanostructures
Aqueous dispersions of MO (MO-NPs) containing various
amounts of (C18)2DTPA(Gd) amphiphilic gadolinium com-
plex (1÷20 %) were prepared by the method previously
described (the list of nanoaggregates are reported in Table 1)
[26]. Briefly, MO, PF127, and (C18)2DTPA(Gd) were
weighed and mixed in chloroform. The weight ratio of
PF127 to MO was 15 % (w/w). After evaporation of the
solvent, the mixture was further dried in a vacuum. A 0.1 M
phosphate buffer at pH 7.4 was added to the dry film, and the
vials were immediately sealed and vortexed for several sec-
onds to distribute water inside the samples. The mixture was
sonicated in a bath sonicator for 30 min and left overnight
under stirring. Finally, solutions were homogenized by
ULTRA-TURRAX®(IKA® T18 basic) for 15 min in ice at
2.5 Hz.
Doxorubicin loading
Doxorubicin was remote-loaded in pure MO and in mixed
MO/(C18)2DTPA-Gd nanostructures (1÷20 molar ratios) by
using the ammonium sulfate gradient method [31]. Briefly,
nanostructure suspension (98/2 w/w H2O/MO) was prepared
as above reported in an ammonium sulfate solution (250 mM)
at pH 5.5. After preparation, nanostructures were eluted on a
Sephadex G-50 column pre-equilibrated with HEPES buffer
(10 mM) at pH 7.4 and then incubated with an aqueous
solution of Dox (3 mg/0.5 mL). The drug loading was studied
at several gDrug/gLipid ratios (0.05÷0.20). The suspension was
stirred for 30 min at 60 °C, and subsequently, unloaded Dox
was removed by gel filtration on a Sephadex column. The
Dox concentration in all experiments was determined by UV–
vis spectroscopy using calibration curves obtained by measur-
ing absorbance at λ=480 nm. The drug-loading content
(DLC; defined as the weight ratio of encapsulated Dox versus
the olein forming nanostructures) was quantified by subtrac-
tion of the amount of removed Dox from the total amount of
loaded Dox.
Physicochemical characterization
Dynamic light scattering
DLS measurements were performed with a homemade instru-
ment composed by a Photocor compact goniometer, an SMD
6000 Laser Quantum 50 mW light source operating at
5,325 Å, a photomultiplier (PMT-120-OP/B), and a correlator
(Flex02-01D) from Correlator.com. All measurements were
performed at (25.00±0.05 °C) with temperature controlled
through the use of a thermostat bath. In DLS, the intensity
autocorrelation function g(2)(t) is measured and related to
the electric field autocorrelation function g(1)(t) by the
Siegert relation. This latter function can be written as the
inverse Laplace transform of the distribution of the relaxa-
tion rate Γ used to calculate the translational diffusion
coefficient D=Γ/q2:
g 1ð Þ tð Þ ¼
Zþ∞
−∞
τA τð Þexp − t
τ
 
d lnτ ð1Þ
where τ=1/Γ and q is the modulus of the scattering vector
q=4πn0/λsin(θ/2), n0 is the refractive index of the solution, λ is
the incident wavelength, and θ represents the scattering angle.
Laplace transforms were performed using a variation of
CONTIN algorithm incorporated in Precision Deconvolve
software. FromLaplace transform, the average of the diffusion
coefficient 〈D〉 and the diffusive polydispersity iD=〈D
2〉/〈D〉2
were obtained.
For spheres diffusing in a continuum medium at infinite
dilution, the diffusion coefficient D∞ is dependent on the
sphere radius RH, called hydrodynamic radius, through the
Stokes–Einstein equation:
RH ¼ kT6πη0D∞
ð2Þ
where k is the Boltzmann constant, T is the absolute temper-
ature, and η0 is the solvent viscosity. For not spherical parti-
cles, RH represents the radius of equivalent spherical
Table 1 Composition
(weight/weight percentage
and molal concentration)
of nanostructures based
on MO
Samples Composition %wt Weight/weight
percentage of
Gd-DTPA(C18)2
[MO]/mmol kg−1 [Gd]/mmol kg−1
A1 MO/D2O – 60.10 –
A2 MO/(C18)2DTPA(Gd)/D2O 1 57.10 0.16
A3 MO/(C18)2DTPA(Gd)/D2O 5 54.80 0.83
A4 MO/(C18)2DTPA(Gd)/D2O 10 50.30 1.58
A5 MO/(C18)2DTPA(Gd)/D2O 20 46.20 3.21
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aggregates. Due to the high dilution, it is possible to make
the approximation: D≅D∞ and η≅η0, where η represents the
solution viscosity. In this hypothesis, Eq. (2) can be rea-
sonably used to estimate the hydrodynamic radius of the
aggregates [32].
Small-angle neutron scattering
SANS measurements were performed at 25 °C with the
KWS2 instrument located at the Heinz Meier-Leibtnitz
Source, Garching Forschungszentrum (Germany). Neutrons
with a wavelength spread Δλ/λ≤0.2 were used. A two-
dimensional array detector at three different wavelength
(W)/collimation (C)/sample-to-detector (D) distance combi-
nations (W7ÅC8mD2m, W7ÅC8mD8m, and W19ÅC8mD8m),
measured neutrons scattered from the samples. These config-
urations allowed collecting data in a range of the scattering
vector modulus q=4π/λsin(θ/2) between 0.0019 and
0.179 Å−1, with θ scattering angle. The investigated systems
were contained in a closed quartz cell in order to prevent the
solvent evaporation and kept under measurement for a period
sufficient to have ~2 million counts. Measurements at very
small angle were performed at KWS3 running on the focusing
mirror principle at the Research Neutron Source Heinz Maier-
Leibnitz (FRM-II) in Garching. Standard configuration of the
instrument with 9.5 m sample-to-detector distances allows
performing scattering experiments with a wave vector transfer
resolution between 10−4 and 3·10−3 Å−1, bridging a gap be-
tween Bonse–Hart and pinhole cameras. Second sample po-
sition at 1.3 m distances has extended Q-range of the instru-
ment to 2·10−2 Å−1 and reached more than one-decade over-
lapping with the classical pinehole SANS instruments. The
principle of this instrument is a one-to-one image of an en-
trance aperture onto a 2D position-sensitive detector by neu-
tron reflection from a double-focusing toroidal mirror. The
raw data were then corrected for background and empty cell
scattering. Detector efficiency correction, radial average, and
transformation to absolute scattering cross sections dΣ/dΩ
were made with a secondary plexiglass standard [33, 34].
For a system composed by a collection of monodisperse
bodies, the scattering cross section dΣ/dΩ, that contains
information on their interactions, sizes, and shapes, can be
expressed as
dΣ
dΩ
¼ npP qð ÞS qð Þ þ dΣdΩ
 
incoh
ð3Þ
where np represents the number density of the scattering
objects in the system, P(q) and S(q) are the form and the
structure factors of the scattering particles respectively, where-
as (dΣ/dΩ)incoh takes into account the incoherent scattering
contribution, mainly due to the presence of hydrogen atoms.
The form factor contains information on the shape of the
scattering objects, whereas the structure factor accounts for
interparticle correlation and is normally important for concen-
trated or charged systems. Structural parameters of the aggre-
gates have been obtained by applying the appropriate models
to the experimental SANS data as described in the “Results
and discussion.”
Results and discussion
Nanoparticles (NPs) of MO containing different amounts of
(C18)2DTPA(Gd) amphiphilic gadolinium complex (1, 5, 10,
and 20 %) (Table 1) were formulated as previously reported
[26]. Pluronic F127 in a 15 % w/w was also added to the
nanoparticle composition; this surfactant acts as stabilizer of
submicron particles with the bicontinuous cubic phase. All
MO formulations showed high relaxivity values per Gd com-
plex (r1p≈11 mM−1 s−1 at 20 MHz and 298 K). These values
did not change in a significant way by changing the Gd(III)
complex content from 1 to 20 % in the nanostructures [26].
The physicochemical characterization has been carried out
through dynamic light scattering and small-angle neutron
scattering. In particular, dynamic light scattering data reveal
the presence of a single broad distribution of aggregates in all
the samples investigated, as shown in Fig. 2. The hydrody-
namic radii RH for all the systems, reported in Table 2, are
located in the range of 70–400 nm. Furthermore, a large
polydispersity is observed for all the analyzed systems being
iD ranged between 1.2 and 1.3 for the samples containing
(C18)2DTPA-Gd .We note that there is a marked difference in
the polydispersity of the systems containing the gadolinium
with respect to that formed by pure MO/PF127. This ob-
servation seems to suggest that the presence of charged
moleculesrepresented by complex, (C18)2DTPA-Gd, does
not affect the average sizes of the aggregates but instead
produce a reduction of the polydispersity that in turn re-
flects in a descrease in the width of the radius distribution
[35].
The morphology of these aggregates, as well as their geo-
metrical characteristics, has been obtained by means of SANS
measurements. Scattering cross sections for all the studied
systems are reported in Fig. 3. Examination of the figure shows
the presence, in the low q region, of a power law (dΣ/dΩ)∝q−α
where α is an exponent ranged between 2 and 4. These values
are characteristic of systems containing multilamellar aggre-
gates, being the exponent α strictly connected to the mean
lamellarity of the supramolecular structure. In the limit case
of α=2, the presence of unilamellar vesicles occurs. According
to the phase diagram at the concentration studied, the MO/
PF127 should form bicontinuous aggregates.
Indeed, the decay of the scattering profile for all the ana-
lyzed systems show a −3 power law at intermediate q values
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(0.004<q<0.015 Å), suggesting a complex structure of the
aggregates as expected for systems containing bicontinuous
aggregates. Furthermore, the scattering profiles observed for
the samples A2, A3, A4, and A5 (i.e., those containing in-
creasing amount of (C18)2DTPA-Gd) are quite similar to that
observed for the system A1 constituted by the pure MO/
PF127 for which bicontinuous aggregates are expected [36].
Because of such evidences, the scattering profile obtained
by SANS measurements has been modeled as a stack of
lamellae. Under these hypothesis, the theoretical expressions
of dΣ/dΩ is:
dΣ
dΩ
qð Þ ¼ 1
q2
f qð Þj j2
D E
1þ f qð Þj jh i
2
f qð Þj j2
D E S qð Þ−1ð Þ
0
@
1
Aþ dΣ
dΩ
 
incoh
ð4Þ
where f (q) is the form factor of a bilayer containing infor-
mation on the shape of the scattering objects, whereas S(q)
is the structure factor that takes into account the interfer-
ences occurring among the bilayers belonging to a single
stack [37, 38].
Finally, (dΣ/dΩ)incoh represents the incoherent contribution
to the cross section measured, mainly due to the presence of
hydrogenated molecules.
From dΣ/dΩ experimental data vs. q several structural
parameters can be optimized by a fitting procedure, namely:
the number of layers in the stack, N, the mean layer thickness,
τ, and the distance between the centers of two consecutive
layers d. Actually, the number of layers N is generally only
approximately determined; it gives rise to the upturn in scat-
tering intensity at low q values where the total thickness of the
stack is seen. In the adopted model, the polydispersity of τ and
d is also admitted: for the former parameter, a Schulz–Zimm
distribution function related to the Zimm polydispersity index
Z is used, while for the latter one d, a Gaussian distribution
with a standard deviation σd was preferred. As shown in
figure, the model succeeds to predict the shape of the scatter-
ing profiles and the structural parameter extract from the fits
are reported in Table 2.
It is worth noting that the pure MO/PF127 nanoaggregates
exhibit a larger value of both hydrodynamic radius and dis-
tance between the centers of two consecutive layers d with
respect to the systems in the presence of Gd complex. It likely
that in the former system, there is a coexistence of
multilamellar aggregates (larger size) and cubosomes (smaller
size) and that upon addition of (C18)2DTPA-Gd, the vesicles
reorganize in cubosome [26, 39].
In conclusion from the structural point of view, the physi-
cochemical characterization suggests that the cubosome can
be lodge a considerable amount of amphiphilic contrast agent
without that this latter destabilizes the bicontinuous structure.
The drug-loading capability of monoolein-based nano-
structures was also investigated. Dox encapsulation into the
nanostructures was carried out by using the sulfate ammonium
gradient method previously performed in anionic-chelating-
containing liposomes [40]. The other method (namely the pH
method) largely employed for the doxorubicin loading was
1 10 100 1000 10000
A2
A5
A4
A3
RH
(nm)
A1
Fig. 2 Example of the hydrodynamic radii distribution at 90° of the
aggregates present in the systems analyzed. For all the systems, the
concentration was 0.2 mmol kg−1
Table 2 Mean characteristic physicochemical parameters obtained for
the analyzed systems
Sample <RH>(nm) iD τ (nm) N d (nm) σd
A1 176±5 1.3 2.8±0.1 12±1 9.2±1.0 0.7±0.1
A2 144±4 1.1 2.8±0.2 14±2 5.4±0.7 0.6±0.1
A3 146±4 1.2 3.0±0.1 12±1 4.5±0.5 0.7±0.1
A4 140±5 1.2 3.0±0.2 11±3 6.3±0.8 0.6±0.1
A5 142±5 1.1 3.4±0.1 12±2 5.7±0.8 0.6±0.1
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Fig. 3 Neutron scattering profiles of the studied systems. Lines corre-
spond to the fitting equations as reported in the text. For a better visual-
ization, data have been multiplied for a scale factor indicated in the plot
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not pursuable because of the poor solubility of nanostructures
at pH 4.0. In particular, nanostructures containing high per-
centage of gadolinium complexes, in which the head group
presents a COO− group, show very low solubility and thus
precipitate. DLC of pure monoolein was 95 % at drug/lipid
(w/w) ratio of 0.15. When the amount of the (C18)2DTPA-Gd
increases in the nanostructure, the DLC slowly decreases until
70 % for the mixed nanostructures containing 20 % of the
gadolinium complex. A DLC of 95 % was obtained by
performing the doxorubicin encapsulation at drug/lipid (w/w)
ratio of 0.10.
Conclusion
A deep structural characterization of nanoaggregates based on
monoolein and Pluronic PF127 containing different amounts
of the amphiphilic Gd complex is necessary to define the
external and internal structures of the cubic mesophases. The
amphiphilic Gd complex containing aggregates shows the
same morphology of the pure MO/PF127 aggregates up to
20 % in mole of (C18)2DTPA-Gd. This suggests that the size
and shape of the aggregates are mainly derived by these two
components and that the amphiphilic contrast agent can be
introduced in the formulation without any loss in the aggre-
gates structure. The bicontinous aggregates show a size of
14 nm, a thickness of the bilayers of about 3 nm with a mean
distance between the centers of the layers of about 5 nm.
Relaxometric properties, size, and shape of the nanostruc-
ture as well the doxorubicin-loading ability suggest that the
obtained nanocompounds could act as theranostics for simul-
taneous cancer therapy and MRI visualization.
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